Quintiles Phase I Services — Overland Park, Kansas

Quintiles Phase I Services is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Quintiles Phase I Services has participated in 8 clinical trials.

Therapeutic areas: TB Multi-drug Resistant, Anthrax, Ebola Hemorrhagic Fever.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), PharmAthene, Inc., Sarepta Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quintiles Phase I Services?

Quintiles Phase I Services has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quintiles Phase I Services conducted?

Quintiles Phase I Services has 8 clinical trials on record. Their work covers TB Multi-drug Resistant, Anthrax, Ebola Hemorrhagic Fever.

Is Quintiles Phase I Services accredited by Crixeo Clinical Trials?

Quintiles Phase I Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quintiles Phase I Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.